当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3807598
已选条件
-
T7749ALB-127158;化合物 T7749ALB-127158
ALB-127158(a) is a potent and selective melanin concentrating hormone 1 ( MCH 1 ) receptor antagonist which may be a potential treatment for inflammatory bowel disease (IBD).
价 格:¥电议型 号:T7749产 地:中国大陆
-
T77484Atibuclimab;阿替布利单抗Atibuclimab
Atibuclimab is a chimeric monoclonal antibody targeting CD14, consisting of a mouse variable region and a human IgG4 Fc region. Atibuclimab can be used to treat amyotrophic lateral sclerosis. Atibuclimab reduces LPS-induced disease and inhibits LPS-induced pro-inflammatory cytokine release, delaying the release of anti-inflammatory cytokine soluble TNF receptor type I.
价 格:¥电议型 号:T77484产 地:中国大陆
-
T77480Bivatuzumab;比伐珠单抗BIWA 4;BIWA 4
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
价 格:¥电议型 号:T77480产 地:中国大陆
-
T7748Dermorphin TFA皮啡肽三氟乙酸盐皮啡肽三氟乙酸盐
Dermorphin TFA is a new class of opioids-like peptides
价 格:¥电议型 号:T7748产 地:中国大陆
-
T77478Milatuzumab;米拉组单抗hLL1|||MEDI-115;hLL1|||MEDI-115
Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
价 格:¥电议型 号:T77478产 地:中国大陆
-
T77477Polatuzumab;维泊妥珠单抗Polatuzumab
Polatuzumab is a monoclonal antibody that targets CD79b and carries chemotherapeutically active molecules.Polatuzumab adheres to CD79b proteins and transports the chemotherapeutically active molecules into cells to kill them.Polatuzumab can be used to synthesize the antibody-compound coupling, Polatuzumab Vedotin.
价 格:¥电议型 号:T77477产 地:中国大陆
-
T77471Tinurilimab;替奴瑞利单抗BAY 1834942;BAY 1834942
Tinurilimab (Bay 1834942) is a monoclonal antibody that targets and inhibits CEACAM6, an immune checkpoint regulator. Tinurilimab can be used in studies about effector T-cells against tumors.
价 格:¥电议型 号:T77471产 地:中国大陆
-
T7747Datelliptium chloride hydrochloride;化合物T7747Datelliptium chloride hydrochloride
Datelliptium chloride hydrochloride is a DNA-intercalating agent derived from ellipticine. with anti-tumor activities.
价 格:¥电议型 号:T7747产 地:中国大陆
-
T77466Tremelimumab;曲美木单抗Ticilimumab|||CP-675206;Ticilimumab|||CP-675206
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.
价 格:¥电议型 号:T77466产 地:中国大陆
-
T7746Eltoprazine dihydrochloride;化合物Eltoprazine dihydrochlorideEltoprazine dihydrochloride
Eltoprazine dihydrochloride is a drug that had previously been developed for aggression, has recently been investigated for L-DOPA-induced dyskinesia in animal models of Parkinson′s disease (PD) and in dyskinetic PD patients.
价 格:¥电议型 号:T7746产 地:中国大陆
-
T77457Emicizumab;艾米珠单抗ACE 910|||RO 5534262;ACE 910|||RO 5534262
Emicizumab(ACE 910) is a humanized monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A. It has been shown to be effective in the treatment of hemophilia A. It has been shown to be effective in the prevention and treatment of hemophilia A.
价 格:¥电议型 号:T77457产 地:中国大陆
-
T77456Lumiliximab;鲁昔单抗IDEC-152|||ST-152;IDEC-152|||ST-152
Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases.
价 格:¥电议型 号:T77456产 地:中国大陆
-
T77455Burosumab;布洛舒单抗KRN23;KRN23
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
价 格:¥电议型 号:T77455产 地:中国大陆
-
T77450Vantictumab;化合物 vantictumabOMP-18R5;OMP-18R5
Vantictumab (OMP-18R5), a fully human IgG2 monoclonal antibody, antagonizes Wnt pathway signaling through binding to FZD1/2/5/7/8 receptors. It is currently under investigation for the treatment of various cancers, including metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma [1] [2].
价 格:¥电议型 号:T77450产 地:中国大陆
-
T77448Naxitamab;那昔妥单抗Naxitamab-gqgk|||Humanized 3F8|||Hu3F8;Naxitamab-gqgk|||Humanized 3F8|||Hu3F8
Naxitamab (Hu3F8) is a humanized monoclonal antibody against GD2 (hu3F8). Naxitamab has antitumor activity and can be used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers.
价 格:¥电议型 号:T77448产 地:中国大陆
-
T77443Racotumomab;雷妥莫单抗Racotumomab
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is a mouse γ-type anti-recombinant antibody. It can specifically induce an antibody response against Neu-glycolyl GM3 ganglioside (NeuGcGM3), which is overexpressed in a variety of solid tumors. Racotumomab reacts with gangliosides containing NU-Glycolyl (NeuGc), thioglycosides, and other antigens expressed in tumors. Racotumomab has anti-cancer activity and can be used in the study of lung cancer.
价 格:¥电议型 号:T77443产 地:中国大陆
-
T77442Glenzocimab;格仑西单抗ACT017;ACT017
Glenzocimab (ACT017) is a Fab fragment of a humanized anti-GPVI monoclonal antibody. Glenzocimab demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model. Glenzocimab has been studied in acute ischemic stroke and cerebral thrombosis.
价 格:¥电议型 号:T77442产 地:中国大陆
-
T77440Codrituzumab;考曲妥珠单抗RG-7686|||RO5137382|||GC33;RG-7686|||RO5137382|||GC33
Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC).
价 格:¥电议型 号:T77440产 地:中国大陆
-
T77439Glembatumumab;格巴妥木单抗Glembatumumab
Glembatumumab is a fully human IgG2 monoclonal antibody targeting the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma.Glembatumumab is a naked antibody to Glembatumumab vedotin and can be used to study antibody-activated molecule couplings (Glembatumumab vedotin ).
价 格:¥电议型 号:T77439产 地:中国大陆
-
T77437Telisotuzumab;特立妥珠单抗ABT-700|||Mab-224G11;ABT-700|||Mab-224G11
Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.
价 格:¥电议型 号:T77437产 地:中国大陆